United States: The Stoned Age: What The CBD Craze Means For Employers And Their Substance Abuse Policies

Last Updated: July 8 2019
Article by Jennifer L. Mora

Seyfarth Synopsis: The federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% of THC (tetrahydrocannabinols) are now considered Schedule V drugs provided they are approved by the federal Food and Drug Administration (FDA). The move marked the first time the DEA removed any form of cannabis from Schedule I and was due to the FDA's approval of Epidiolex, a non-synthetic cannabis-derived medicine used to treat severe epilepsy. Yet, setting aside this very limited exception, marijuana and CBD remain illegal under federal law. And while CBD is projected to be a $22 billion industry by 2022, many employers remain hazy about this extremely popular product and the implications it has on their employees and businesses.

The Science Behind CBD

Hemp and marijuana are different strains of the cannabis sativa plant. Despite being derived from the same plant, there are differences between hemp and marijuana.

Hemp is a strain of cannabis that historically has been used to make industrial products, including cement, paper, clothing, and more. At present, hemp is no longer a Schedule I controlled substance but, instead, is now classified as an agricultural commodity provided its THC concentration does not exceed 0.3%, an amount generally viewed to be too low to produce a psychoactive effect.

Marijuana, on the other hand, has a higher THC concentration, the main ingredient that produces the psychoactive effect and makes people feel high. Marijuana has been listed as a Schedule I controlled substance since 1972. Being labeled a Schedule I drug means, according to the federal Controlled Substances Act, the drug has no currently accepted medical use and has a high potential for abuse. Additional Schedule I drugs include heroin, LSD, and ecstasy. Federal law considers marijuana to be more dangerous than cocaine, which presently is a Schedule II drug.

Marijuana and hemp both contain CBD, which is now being marketed and sold in a variety of forms, including oil (the most popular), health and beauty products, vapors, beverages, and infused edibles, such as chocolates and gummies. Pure CBD usually will not report a positive test result for marijuana because drug tests typically look for THC levels that are too high to be detected from pure CBD. For this reason, according to the National Institute on Drug Abuse, employees generally are not at risk of becoming intoxicated or impaired if they use pure CBD. However, if the CBD product contains a sufficient amount of THC, it is entirely possible the product could cause a positive drug test result for marijuana. Regardless, the DEA still considers CBD a Schedule I controlled substance and, thus, illegal under federal law.

A Product in Need of Regulatory Oversight?

A potential issue with CBD is that it remains unregulated and, thus, consumers, including employees, are left in dark about what they actually are ingesting. According to the National Organization for the Reform of Marijuana Laws (NORML), while some studies have shown that CBD can have therapeutic benefits, including anti-convulsant, anti-psychotic, analgesic, and anti-diabetic effects, it notes that some CBD products may not be living up to how they are being marketed in terms of both quality and safety. Specifically, NORML wrote, "in almost all instances, commercially available CBD products contain far lower quantities of CBD than are necessary to yield therapeutic effects in clinical trials." And, some products that tout themselves as being either "THC-free" or pure CBD do, in fact, have THC or some other chemical or synthetic drug. In a recent study in Forensic Science International, researchers tested nine CBD oils and found that two of the oils had THC and four had 5-fluoro MDMB-PINACA (5F-ADB), a Schedule I controlled substance that is known on the street as "Spice." This is important because in 2014, the DEA reported 2,311 incidents involving medical intervention or death relating to 5F-ADB.

The FDA has these same concerns and recently held hearings to determine how best to regulate CBD products. The outgoing director of the FDA testified to Congress that it could take several years before the FDA will be in a position to regulate CBD given what he views will be a "highly novel rulemaking process." More recently, the FDA noted while it "recognize[d] the potential benefits of CBD," it remains concerned about public safety. For example, during its review of Epidiolex, it discovered that CBD can cause harm to the liver, a claim many dispute as being based on a flawed scientific methodology. The FDA also pointed to what they view to be "unsubstantiated therapeutic claims" that CBD can treat serious illnesses, which might result in consumers avoiding medical treatment in favor of a product with potentially limited medicinal value. How and when the FDA intends to address the issue remains to be seen.

What Should Employers Do?

While marijuana and CBD are illegal under federal law, the CBD trend is expected to get trendier. Forbes Magazine recently reported that CBD sales in the United States alone are expected to reach $22 billion by 2022. Beyond CBD, more than half of the states have enacted medical marijuana laws and more than 10 jurisdictions allow adults to use marijuana recreationally. And, states are getting in the business of legalizing and regulating CBD, including Florida, Georgia, Iowa, Texas, Wisconsin, and Wyoming, among others. There is every reason to believe that more states will follow suit.

Recreational marijuana laws still allow employers latitude in enforcing their drug and alcohol testing and substance abuse policies. On the other hand, how an employer treats a job applicant or employee using medical marijuana will vary by state. Employers in jurisdictions with pot friendly laws should carefully consider whether they can simply state that they follow federal law and, thus, any marijuana use is a violation of company policy. Of course, employers subject to the Department of Transportation's drug and alcohol testing regulations (Part 40) cannot ignore a positive test for marijuana, even if used medicinally.

CBD presents the same challenges to employers as does medical marijuana with the potential for additional problems. Do applicants and employees really know what's in their CBD product and the impact, if any, that such use might have on their employment? If an employee justifies a positive marijuana test result by their CBD use and presents the employer what appears to be a "CBD pure" product as proof, how will an employer know what caused the positive result – is the employee smoking recreational marijuana or using what they genuinely believe to be an unregulated "pure" CBD product that unfortunately is spiked with THC? In states that do not have medical marijuana laws, the burden falls squarely on the applicant or employee to prove they are not using marijuana. However, in medical marijuana states, the employer may (depending on the state at issue) have a duty to accommodate the underlying medical condition prompting CBD or medical marijuana use or may be restricted in its ability to take action based on solely a positive marijuana test result.

We continue to recommend that employers exercise caution when dealing with applicants and employees using medical marijuana. The same holds true for CBD. Before taking any action against medical marijuana or CBD users, employers should review the laws of the states in which they operate and work with employment counsel to help navigate this complex and rapidly evolving area of the law.

Employers also may need to consider:

  • revising their policies to address CBD use;
  • training their managers and supervisors on how to address situations where an employee defends a positive drug test by claiming use of CBD;
  • educating employees about CBD; and
  • having a conversation with their drug testing providers about CBD and the lab's drug testing and reporting processes.

Seyfarth Shaw will continue to monitor legal developments at the federal and state level.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions